Disagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening.
We aimed to determine the disagreement in primary cervical screening between four human papillomavirus assays: Hybrid Capture 2, cobas, CLART, and APTIMA. Material from 5,064 SurePath samples of women participating in routine cervical screening in Copenhagen, Denmark, was tested with the four assays...
Guardado en:
Autores principales: | Matejka Rebolj, Sarah Preisler, Ditte Møller Ejegod, Carsten Rygaard, Elsebeth Lynge, Jesper Bonde |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3160af342dcb4f6eb54102b13a5fdef5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay.
por: Sarah Preisler, et al.
Publicado: (2013) -
Illocutionary Disagreement in Faultless Disagreement
por: Natalia Karczewska
Publicado: (2021) -
Abbott Alinity m HR-HPV, a novel human papillomavirus assay for primary cervical cancer screening, is adapted to HPV guidelines
por: Lina Mouna, et al.
Publicado: (2021) -
Disagreements of the Jurists
por: Yasmin Amin
Publicado: (2017) -
Faultless Disagreement Contextualism
por: Alex Davies
Publicado: (2021)